TC Medical(SH:600763) Sou Hu Cai Jing·2025-11-26 12:28Core Viewpoint - Tongce Medical (600763) reported a slight decline in stock price, with a closing price of 41.9 yuan on November 26, 2025, down 0.12% from the previous day [1] Financial Performance - For the first three quarters of 2025, Tongce Medical achieved a main business revenue of 2.29 billion yuan, a year-on-year increase of 2.56% [3] - The net profit attributable to shareholders was 514 million yuan, up 3.16% year-on-year [3] - The third quarter alone saw a main business revenue of 842 million yuan, reflecting a 2.34% increase year-on-year [3] - The company reported a gross profit margin of 41.69% and a net profit margin of 26.91% [3] Market Position - Tongce Medical's total market capitalization is 18.741 billion yuan, ranking 8th in the medical services industry [3] - The company has a price-to-earnings ratio (P/E) of 27.37, significantly lower than the industry average of 366.11, ranking 3rd in the industry [3] - The return on equity (ROE) stands at 11.8%, placing it 5th in the industry [3] Fund Flow Analysis - On November 26, 2025, the net inflow of main funds was 9.8015 million yuan, accounting for 5.38% of the total transaction amount [1][2] - Retail investors experienced a net outflow of 11.9863 million yuan, representing 6.58% of the total transaction amount [1][2] - Over the past five days, the stock has seen fluctuations in fund flows, with notable net outflows from retail investors on several days [2] Analyst Ratings - In the last 90 days, 10 institutions have rated the stock, with 7 buy ratings and 3 hold ratings [4] - The average target price set by analysts over the past 90 days is 51.78 yuan [4]